Details for New Drug Application (NDA): 076897
✉ Email this page to a colleague
NDA 076897 describes OXANDROLONE, which is a drug marketed by Par Pharm, Roxane, Sandoz, and Upsher Smith Labs, and is included in five NDAs. It is available from one supplier. Additional details are available on the OXANDROLONE profile page.
The generic ingredient in OXANDROLONE is oxandrolone. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the oxandrolone profile page.
The generic ingredient in OXANDROLONE is oxandrolone. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the oxandrolone profile page.
Summary for 076897
| Tradename: | OXANDROLONE |
| Applicant: | Sandoz |
| Ingredient: | oxandrolone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 076897
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
| Approval Date: | Dec 1, 2006 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Dec 1, 2006 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
